Arrowstreet Capital, Limited Partnership X Biotech Inc. Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$15.65 - $19.92 $408,105 - $519,453	-26,077 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$13.97 - $21.16 $803,777 - $1.22 Million	-57,536 Reduced 68.81%	26,077 $498,000
Q2 2020 Aug 12, 2020	SELL	$10.39 - $16.07 $170,998 - $264,480	-16,458 Reduced 16.45%	83,613 $1.15 Million
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $100,154 - $280,974	11,266 Added 12.69%	100,071 $1.06 Million
Q4 2019 Feb 13, 2020	BUY	$8.33 - $19.95 $739,745 - $1.77 Million	88,805 New	88,805 $1.66 Million

4.7M

200

12.8K

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $94.4M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.